Celltrion And Teva Catch Up On Canadian Trastuzumab

Canada_Thumbs_Up
Health Canada has approved Celltrion and Teva’s trastuzumab biosimilar • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products